Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. J of Skin 2022, 6 (6), s52. https://doi.org/10.25251/skin.6.supp.52.